This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Health technology
The study examined the use of a screening protocol that incorporated a global deep vein thrombosis (DVT) pretest probability (PTP) ascertained by a questionnaire, a selective D-dimer assay, and selective venous duplex imaging (VDI) to exclude the diagnosis of DVT in emergency department (ED) patients. The ED doctor filled in a questionnaire (developed by Wells et al. See "Other Publications of Related Interest" below) after clinical examination. This was used to calculate a PTP of DVT. The patients were then divided into three categories based on their PTP score: low, moderate and high risk.
Type of intervention
Screening and diagnosis.
Economic study type
Cost-effectiveness analysis.
Study population
The study population comprised patients admitted to the ED of a hospital who were suspected, by the ED doctor, of having DVT.
Setting
The setting was secondary care. The economic study was carried out in the USA.
Dates to which data relate
Effectiveness evidence was collected during the period 1 April 2000 -31 March 2001. Dates for resource use were not given but it can be inferred that they were the same as those for the effectiveness evidence. No price year was given but cost data were only collected for one year.
Source of effectiveness data
Effectiveness data were derived from a single study.
Link between effectiveness and cost data
Prospective costing was carried out on the same sample of patients as that used in the effectiveness analysis.
Study sample
No power calculations were reported. There was no sample selection; all 114 patients with suspected DVT presenting during the study period were included in the study. All patients were supposed to receive all the tests.
Study design
This was a prospective cross-sectional diagnostic study, conducted in a single centre.
Analysis of effectiveness
The effectiveness analysis was based on intention to treat. The effectiveness of the screening protocol was measured by its sensitivity, specificity, the positive predictive value (PPV) and the negative predictive value (NPV). All patients were given all tests; subsequently correlation studies were completed using VDI as the gold standard. The screening strategy was considered positive when the patient had been correctly placed in the high-risk group by their PTP or the Ddimer was positive, thus ensuring the patient received the correct treatment. The VDI tests were used to establish a definitive diagnosis of DVT. The screening strategy would initially give patients VDI only if they had reached a highrisk score in the PTP, otherwise they would receive D-dimer. If the D-dimer test was positive they would then receive VDI.
Effectiveness results
Although the study was intended to give all 114 patients D-dimer and PTP, 66 patients had PTP and D-dimer, but 95 patients only had D-dimer. The reason for this was "lack of attentiveness" by the doctors in the ED.
All 11 patients (9.6%) diagnosed with DVT using the VDI test were in the high risk category as defined by the PTP, although 5 of these patients had their PTP calculated retrospectively after the VDI had identified them as having DVT.
The results for D-dimer as a single test were: sensitivity 80%, specificity 41%, PPV 14%, negative predictive value 95%.
The results for D-dimer and PTP together as a test were: sensitivity 100%, specificity 25%, PPV 12%, negative predictive value 100%.
Clinical conclusions
Using the proposed screening algorithm to identify patients with suspected DVT ED doctors could safely reduce referrals to VDI by 23%.
Measure of benefits used in the economic analysis
No summary measure of benefit was used.
Direct costs
Costs were based on hospital charges for the different tests. Costs were calculated for the screening strategy and compared with routine global VDI. The costs of carrying out the PTP were not calculated, and thus only the costs of the VDI and the D-dimer were included. The costs of the tests were reported separately from the quantities. Those costs were based on actual data. No price year was reported.
